Gastroenterology
Volume 134, Issue 4 , Pages 953-959.e1 , April 2008

Parental Obesity and Offspring Serum Alanine and Aspartate Aminotransferase Levels: The Framingham Heart Study

  • Rohit Loomba

      Affiliations

    • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • ,
  • Shih–Jen Hwang

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • ,
  • Christopher J. O’Donnell

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • R. Curtis Ellison

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
    • ,
  • Ramachandran S. Vasan

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • Sections of Cardiology and Preventive Medicine & Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts
    • ,
  • Ralph B. D’Agostino Sr

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • Department of Mathematics, Boston University, Boston, Massachusetts
    • ,
  • T. Jake Liang

      Affiliations

    • Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • ,
  • Caroline S. Fox

      Affiliations

    • Framingham Heart Study, National Heart and Blood and Lung Institute, National Institutes of Health, Framingham, Massachusetts
    • Department of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationAddress requests for reprints to: Caroline S. Fox, MD, MPH, 73 Mt Wayte Avenue, Suite #2, Framingham, Massachusetts 01702.

Received 22 July 2007 ,Accepted 20 December 2007.

References 

  1. Seidell JC. Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr. 2000;83(suppl 1):S5–S8
  2. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–1688
  3. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  4. Li C, Ford ES, McGuire LC, et al. Increasing trends in waist circumference and abdominal obesity among U.S. adults. Obesity (Silver Spring). 2007;15:216–224
  5. Peters ET, Seidell JC, Menotti A, et al. Changes in body weight in relation to mortality in 6441 European middle-aged men: the Seven Countries Study. Int J Obes Relat Metab Disord. 1995;19:862–868
  6. Menotti A, Lanti M, Maiani G, et al. Determinants of longevity and all-cause mortality among middle-aged men (Role of 48 personal characteristics in a 40-year follow-up of Italian Rural Areas in the Seven Countries Study). Aging Clin Exp Res. 2006;18:394–406
  7. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000 [see comment]. JAMA. 2002;288:1728–1732
  8. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States [see comment]. Gastroenterology. 2003;124:71–79
  9. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002. Am J Gastroenterol. 2006;101:76–82
  10. Neuschwander-Tetri BA. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci. 2005;330:326–335
  11. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52
  12. Meltzer AA, Everhart JE. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol. 1997;146:565–571
  13. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–728
  14. Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring). 2006;14:529–644
  15. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol. 2006;101:76–82
  16. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395
  17. Browning JD, Kumar KS, Saboorian MH, et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol. 2004;99:292–298
  18. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med. 2000;108:9–13
  19. Willner IR, Waters B, Patil SR, et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001;96:2957–2961
  20. Bathum L, Petersen HC, Rosholm JU, et al. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001;47:81–87
  21. Cupples LA DARB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In:  Kannel WB,  Polf PA,  Garrison RJ editor. The Framingham Heart Study: an epidemiological investigation of cardiovascular disease. Washington, DC: Government Printing Office; 1987;NIH Publication 87–203, section 34
  22. Feinleib M, Kannel WB, Garrison RJ, et al. The Framingham Offspring Study (Design and preliminary data). Prev Med. 1975;4:518–525
  23. Henry RJ, Chiamori N, Golub OJ, et al. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960;34:381–398
  24. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–10
  25. Chang Y, Ryu S, Sung E, et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;53:686–692
  26. Abdelmalek MF, Liu C, Shuster J, et al. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2006;4:1162–1169
  27. Merriman RB, Aouizerat BE, Bass NM. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol. 2006;40(Suppl 1):S30–S33
  28. Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 2006;26:1021–1028
  29. Kazumi T, Kawaguchi A, Yoshino G. Associations of middle-aged mother’s but not father’s body mass index with 18-year-old son’s waist circumferences, birth weight, and serum hepatic enzyme levels. Metabolism. 2005;54:466–470
  30. Delplanque J, Barat-Houari M, Dina C, et al. Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in Caucasian families. Diabetologia. 2000;43:1554–1557
  31. Bell CG, Meyre D, Samson C, et al. Association of melanin-concentrating hormone receptor 1 5′ polymorphism with early-onset extreme obesity. Diabetes. 2005;54:3049–3055
  32. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356:237–247
  33. Friedman JM. Leptin and the regulation of body weight. Harvey Lect. 1999;95:107–136
  34. Cao Q, Mak KM, Lieber CS. Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J Cell Biochem. 2006;97:188–197
  35. Ding X, Saxena NK, Lin S, et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol. 2005;166:1655–1669
  36. Kitade M, Yoshiji H, Kojima H, et al. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology. 2006;44:983–991
  37. Reik W, Walter J. Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote. Nat Genet. 2001;27:255–256
  38. Nordfjall K, Larefalk A, Lindgren P, et al. Telomere length and heredity: indications of paternal inheritance. Proc Natl Acad Sci U S A. 2005;102:16374–16378
  39. Salvaggio A, Periti M, Miano L, et al. Body mass index and liver enzyme activity in serum. Clin Chem. 1991;37:720–723
  40. Kojima H, Sakurai S, Uemura M, et al. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res. 2005;29(12 suppl):259S–263S
  41. Panteghini M. Aspartate aminotransferase isoenzymes. Clin Biochem. 1990;23:311–319
  42. Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol. 1994;21:739–743

 Supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (N01-HC-25195), K-24-HL-04334 (VR), and the intramural training program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funding agencies had no role in data analysis or reporting.

 The authors report no conflict of interest.

PII: S0016-5085(08)00111-X

doi: 10.1053/j.gastro.2008.01.037

Gastroenterology
Volume 134, Issue 4 , Pages 953-959.e1 , April 2008

Article Tools